marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-04-2024
Adverum Biotechnologies Cash Flow 2011-2024 | ADVM
Annual Cash Flow Adverum Biotechnologies
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-90.9 M | -108 M | -108 M | -79.3 M | -49.2 M | -54 M | -45.4 M | - | - | - | - | - | - |
Depreciation & Amortization |
5.64 M | 6.53 M | 4.64 M | 4.16 M | 1.57 M | 1.75 M | 2.1 M | 1.6 M | 812 K | 162 K | 26 K | 1 K | - |
Accounts Payables |
1.92 M | 2.24 M | 1.39 M | 2.81 M | 4.1 M | 1.71 M | 1.73 M | 1.47 M | 605 K | 951 K | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | 886 K | 449 K | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Adverum Biotechnologies
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -23.2 M | - | - | -22.4 M | - | -89.6 M | -57.8 M | -28.9 M | - | -82 M | -56.2 M | -22.3 M | - | -57.1 M | -30.5 M | -13.6 M | - | -34.3 M | -24.8 M | -13.2 M | - | -41.2 M | -24.3 M | -13 M | - | -33.2 M | -23.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | 997 K | - | - | 1.59 M | - | 4.82 M | 3.03 M | 1.42 M | - | 3.32 M | 2.36 M | 1.17 M | - | 1.2 M | 1.3 M | 599 K | - | 400 K | 400 K | 426 K | - | 400 K | 500 K | 459 K | - | 500 K | 600 K | 516 K | - | 400 K | 300 K | 320 K | - | 241 K | 147 K | 118 K | - | 49 K | 25 K | 9 K | - | 7 K | 7 K | - | - | - | - | - | - | - | - | - |
Accounts Payables |
2.11 M | 1.97 M | 1.9 M | 2.17 M | 1.42 M | 2.86 M | 2.24 M | 846 K | 4.7 M | 3.24 M | 1.39 M | 2.52 M | 2.26 M | 2.06 M | 2.81 M | 2.81 M | 2.81 M | 2.81 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 1.71 M | 1.71 M | 1.71 M | 1.71 M | 1.73 M | 1.73 M | 1.73 M | 1.73 M | 1.47 M | 1.47 M | 1.47 M | 1.47 M | 605 K | 605 K | 605 K | 605 K | 951 K | 951 K | 951 K | 951 K | 769 K | 769 K | 769 K | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 886 K | 886 K | 886 K | 886 K | 449 K | 449 K | 449 K | 449 K | - | 8 K | 8 K | - | 8 K | 8 K | 8 K | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency